Suppr超能文献

针刺联合中药预防子宫内膜异位症腹腔镜术后复发的疗效观察

[Efficacy observation on the combination of acupuncture and Chinese medication in prevention of the recurrence of endometriosis after laparoscopic surgery].

作者信息

Zhang Xiao-Yun, Zhang Chun-Yan

出版信息

Zhongguo Zhen Jiu. 2014 Feb;34(2):139-44.

Abstract

OBJECTIVE

To evaluate the efficacy and safety of acupuncture-moxibustion combined with modified Mojie tablet (see text) in the prevention of the recurrence of endometriosis (EMS) after laparoscopic surgery.

METHODS

After laparoscopic surgery, 120 cases of EMS were randomized into an acupuncture-moxibustion group, a western medication group, a Chinese medication group and a combined therapy of acupuncture-moxibustion and Chinese medication group (combined therapy group), 30 cases in each one. In the acupuncture-moxibustion group, acupuncture was applied at Xuehai (SP 10), Sanyinjiao (SP 6) and Guanyuan (CV 4); the isolated moxibustion with ginger was used at Guanyuan (CV 4), once a day, twice a week. In the western medication group, gestrinone was prescribed for oral administration, 2.5 mg, once a day, twice a week. In the Chinese medication group, the self-prepared Mojie tablet were prescribed for oral administration. In the combined therapy group, acupuncture, moxibustion and modified Mojie tablet for oral administration were used in combination. The therapeutic methods were same as the acupuncture-moxibustion group and the Chinese medication group. Totally, the treatment of 3 months was required. Separately, before treatment, after treatment, in 3 months after treatment and in 6 months after treatment, EHP-5 score (endometriosis health profile-5), the abdominal/vaginal ultrasound examination, serum CA125 detection and safety index (ALT detection) were compared in patients among 4 groups.

RESULTS

In 3 and 6 months after treatment, the positive rates of EHP-5 score were 0% (0/30) in the combined therapy group and 0% (0/30) in the acupuncture-moxibuston group, which were all lower significantly than 13.3% (4/30) in the western medication group (both P < 0.05). In follow-up stage of 6 months after treatment, there was no recurrence case in abdominal lviginal ultrasound examination in the combined therapy group, which was lower than 13.3% (4/30) in the western medication group (P < 0.05); the serum CA125 detection in the combined therapy group did not find any abnormal case, which was lower than 16.7% (5/30) in the western medication group (P < 0.05). At the end of treatment session and in the follow-up stage of 3 months after treatment, the abnormal rate of ALT were 20.0% (6/30) and 13.3% (4/30) in the western medication group, which were higher than those in any of the rest groups (P < 0.05). In the follow-up stage of 6 months after treatment, there were 3 abnormal cases of ALT in the western medication group, but which was not different significantly as compared with the rest groups (P > 0.05).

CONCLUSION

Acupuncture and moxibustion combined with modified Mojie tablet effectively prevent from the recurrence of EMS after laparoscopic surgery and improve the life quality of the patients. This combined therapy brings less damage on the liver as compared with the western medication of gestrinone and indicates its definite efficacy and safety.

摘要

目的

评价艾灸联合改良散结片(见正文)预防腹腔镜手术后子宫内膜异位症(EMS)复发的疗效及安全性。

方法

将120例EMS患者在腹腔镜手术后随机分为艾灸组、西药组、中药组和艾灸联合中药组(联合治疗组),每组30例。艾灸组取血海(SP 10)、三阴交(SP 6)、关元(CV 4)进行针刺;关元(CV 4)采用隔姜灸,每日1次,每周2次。西药组口服孕三烯酮,2.5mg,每日1次,每周2次。中药组口服自拟散结片。联合治疗组采用针刺、艾灸及口服改良散结片联合治疗,治疗方法同艾灸组和中药组。共治疗3个月。分别于治疗前、治疗后、治疗后3个月及治疗后6个月比较4组患者的子宫内膜异位症健康概况-5(EHP-5)评分、腹部/阴道超声检查、血清CA125检测及安全性指标(ALT检测)。

结果

治疗后3个月及6个月,联合治疗组和艾灸组EHP-5评分阳性率均为0%(0/30),均显著低于西药组的13.3%(4/30)(均P<0.05)。治疗后6个月随访期,联合治疗组腹部/阴道超声检查无复发病例,低于西药组的13.3%(4/30)(P<0.05);联合治疗组血清CA125检测未发现异常病例,低于西药组的16.7%(5/30)(P<0.05)。治疗结束时及治疗后3个月随访期,西药组ALT异常率分别为20.0%(6/30)和13.3%(4/30),高于其余各组(P<0.05)。治疗后6个月随访期,西药组有3例ALT异常,但与其余各组比较差异无统计学意义(P>0.05)。

结论

艾灸联合改良散结片能有效预防腹腔镜手术后EMS复发,提高患者生活质量。与孕三烯酮西药相比,该联合治疗对肝脏损伤较小,疗效确切,安全性高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验